Phaedra Chrousos - Jun 10, 2021 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Role: Director
Signature: /s/ Phaedra Chrousos
Stock symbol: VNDA
Transactions as of: Jun 10, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/14/2021, 04:34 PM
Next filing: Jun 15, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNDA	Common Stock	Award	$0	+5K	+50%	$0.00	15K	Jun 10, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VNDA	Stock Option (Right to Buy)	Award	$0	+10K		$0.00	10K	Jun 10, 2021	Common Stock	10K	$19.21	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
F2	This option vests and becomes exercisable with respect to 100% of the option shares on June 10, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.